婴儿血管瘤是婴儿期最常见的良性肿瘤,临床多见。尽管大多数具有自限性的良性病程,但部分仍有导致严重功能障碍及毁容的风险,需要积极治疗。治疗方法多种多样,传统的治疗方法如糖皮质激素、干扰素、长春新碱、手术、激光等副作用大,并非对所有血管瘤都有效。目前β受体阻滞剂以其安全高效的优点成为一线首选药物。 Infantile hemangioma is the most common benign tumor in infancy, more common clinical. Although most have a self-limited benign course, some still have the potential to cause serious dysfunction and disfigurement, requiring active treatment. A wide range of treatment methods, the traditional treatment methods such as glucocorticoids, interferon, vincristine, surgery, laser and other side effects, not all hemangiomas are effective. At present, β-blockers have become the first-line drug of choice for their safe and effective advantages.